SPA17 and ovarian carcinoma: Chiriva‐Internati et al.109immunized mice with the Sp17 protein and found that Sp17 vaccine with CpG deoxynucleotides (CpG ODN) as adjuvant can overcome immune tolerance, inhibit tumor growth, and prolong survival in ovarian cancer mice.